- Home
- EMBC vs KURA Comparison
EMBC vs KURA Comparison
Compare EMBC & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMBC
- KURA
- Stock Information
- Founded
- EMBC 1924
- KURA 2014
- Country
- EMBC United States
- KURA United States
- Employees
- EMBC N/A
- KURA N/A
- Industry
- EMBC Medical/Dental Instruments
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EMBC Health Care
- KURA Health Care
- Exchange
- EMBC Nasdaq
- KURA Nasdaq
- Market Cap
- EMBC 726.8M
- KURA 561.9M
- IPO Year
- EMBC N/A
- KURA N/A
- Fundamental
- Price
- EMBC $10.39
- KURA $6.44
- Analyst Decision
- EMBC Hold
- KURA Strong Buy
- Analyst Count
- EMBC 3
- KURA 12
- Target Price
- EMBC $17.00
- KURA $24.50
- AVG Volume (30 Days)
- EMBC 707.5K
- KURA 1.4M
- Earning Date
- EMBC 08-08-2025
- KURA 08-07-2025
- Dividend Yield
- EMBC 5.59%
- KURA N/A
- EPS Growth
- EMBC N/A
- KURA N/A
- EPS
- EMBC 0.89
- KURA N/A
- Revenue
- EMBC $1,079,500,000.00
- KURA $67,991,000.00
- Revenue This Year
- EMBC N/A
- KURA $125.04
- Revenue Next Year
- EMBC N/A
- KURA $83.75
- P/E Ratio
- EMBC $11.74
- KURA N/A
- Revenue Growth
- EMBC N/A
- KURA N/A
- 52 Week Low
- EMBC $9.20
- KURA $5.41
- 52 Week High
- EMBC $21.48
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- EMBC 50.88
- KURA 59.02
- Support Level
- EMBC $9.97
- KURA $5.65
- Resistance Level
- EMBC $10.87
- KURA $6.46
- Average True Range (ATR)
- EMBC 0.45
- KURA 0.26
- MACD
- EMBC 0.14
- KURA 0.07
- Stochastic Oscillator
- EMBC 71.47
- KURA 97.73
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.